Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.16B |
| 2 |
JPMorgan Chase
JPM
|
+$1.03B |
| 3 |
FedEx
FDX
|
+$857M |
| 4 |
Northrop Grumman
NOC
|
+$818M |
| 5 |
Humana
HUM
|
+$811M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.16B |
| 2 |
Intel
INTC
|
+$1.38B |
| 3 |
Bank of America
BAC
|
+$1.18B |
| 4 |
Verizon
VZ
|
+$1.07B |
| 5 |
Netflix
NFLX
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Technology | 18.46% |
| 3 | Financials | 11.78% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEAL
751
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $40.5M | 0.01% |
1,067,082
-36,898
| -3% | -$1.33M |
|
|
TCRR
752
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $40.5M | 0.01% |
+1,991,090
| New | +$35M |
|
753
Stepan Co
SCL
$1.46B
| $40.3M | 0.01% |
369,528
-163,532
| -31% | -$17.9M |
|
754
Monro
MNRO
$387M
| $40.1M | 0.01% |
988,844
-400,297
| -29% | -$20.4M |
|
|
CAI
755
DELISTED
CAI International, Inc.
CAI
| $40.1M | 0.01% |
1,455,551
-94,400
| -6% | -$1.95M |
|
|
NUAN
756
DELISTED
Nuance Communications, Inc.
NUAN
| $39.9M | 0.01% |
1,203,228
-12,989
| -1% | -$377K |
|
757
J.M. Smucker
SJM
$12.7B
| $39.9M | 0.01% |
345,653
-59,064
| -15% | -$6.58M |
|
758
BioNTech
BNTX
$23.3B
| $39.8M | 0.01% |
574,304
-22,908
| -4% | -$1.64M |
|
759
Ally Financial
ALLY
$13.3B
| $39.7M | 0.01% |
1,584,759
+956,392
| +152% | +$21.4M |
|
|
RDUS
760
DELISTED
Radius Health, Inc.
RDUS
| $39.2M | 0.01% |
3,456,184
-354,038
| -9% | -$4.38M |
|
761
ALX Oncology
ALXO
$279M
| $39M | 0.01% |
+1,034,528
| New | +$40.7M |
|
|
CKH
762
DELISTED
Seacor Holdings Inc.
CKH
| $39M | 0.01% |
1,340,453
-92,803
| -6% | -$2.75M |
|
763
SiriusPoint
SPNT
$2.7B
| $38.9M | 0.01% |
5,593,043
+200,407
| +4% | +$1.62M |
|
764
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $38.8M | 0.01% |
349,822
+45,240
| +15% | +$5.08M |
|
765
Acco Brands
ACCO
$406M
| $38.8M | 0.01% |
6,683,647
-655,667
| -9% | -$4.29M |
|
766
Paycom
PAYC
$10.1B
| $38.6M | 0.01% |
124,096
+11,101
| +10% | +$3.24M |
|
767
UroGen Pharma
URGN
$2.28B
| $38.5M | 0.01% |
1,995,990
-5,602
| -0.3% | -$127K |
|
768
Rocket Pharmaceuticals
RCKT
$392M
| $38.4M | 0.01% |
1,681,605
-7,385
| -0.4% | -$182K |
|
769
SPX Corp
SPXC
$10.8B
| $38.2M | 0.01% |
823,232
-38,719
| -4% | -$1.63M |
|
770
Exponent
EXPO
$3.22B
| $38.1M | 0.01% |
528,670
-63,519
| -11% | -$5.05M |
|
|
RPT
771
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $38M | 0.01% |
6,981,718
-646,967
| -8% | -$3.97M |
|
|
PE
772
DELISTED
PARSLEY ENERGY INC
PE
| $38M | 0.01% |
4,057,549
+848,719
| +26% | +$9.08M |
|
773
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $37.6M | 0.01% |
817,820
+377,180
| +86% | +$17.4M |
|
774
Axcelis
ACLS
$4.29B
| $37.1M | 0.01% |
1,687,237
-279,462
| -14% | -$7.13M |
|
775
iRhythm Holdings
IRTC
$4.27B
| $37.1M | 0.01% |
155,717
-223,831
| -59% | -$39.6M |
|
Similar funds
Wellington Management Group's Q3 2020 Portfolio in Review
As of Q3 2020, Wellington Management Group held 2,048 positions worth $483B, up 7.6% from $449B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wellington Management Group's Q3 2020 filing shows 214 new, 682 increased, 869 reduced and 176 closed positions. Its largest new stake was nCino: 7,715,323 shares worth $598M. The largest sale was Apple, an estimated $2.16B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q3 2020 buy was nCino: 7,715,323 shares worth $598M.
- Wellington Management Group added most to Procter & Gamble in Q3 2020, an estimated $1.16B increase.
- Wellington Management Group's biggest Q3 2020 reduction was Apple, cutting an estimated $2.16B.
- Wellington Management Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $160M.
- Wellington Management Group's ten largest holdings make up 18% of its $483B portfolio in Q3 2020.
- Wellington Management Group opened 214 new positions and closed 176 in Q3 2020.
- Wellington Management Group's portfolio value rose 7.6% quarter-over-quarter to $483B.
Based on Wellington Management Group's 13F filing for Q3 2020, filed 16 Nov 2020.